MIT and Spinout E8 Pharmaceuticals Sue Affymetrix for Alleged Patent Infringement

The Massachusetts Institute of Technology and spinout company E8 Pharmaceuticals, which was founded earlier this year, have filed a lawsuit against Affymetrix alleging that the company’s GeneChip technology infringes on a patent owned by MIT and licensed to E8.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.